Efficacy of Eductyl® Versus Placebo for Treatment of Dyschesia

Laboratoires Techni Pharma306 enrolled

Overview

The purpose of this study is to assess the efficacy of Eductyl versus placebo for treatment of patients with dyschesia treated by rectal rehabilitation.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

306

Conditions

Dyschesia

Interventions

Eductyl suppositoryDRUG

one suppository every morning during 21 days

Placebo suppositoryDRUG

placebo suppository every morning during 21 days

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female over 18 years * Patients with dyschesia * Prescription of rehabilitation for dyschesia Exclusion Criteria: * Rectal diseases * Pain killers * Pregnant women * Breast feeding patients * Non-compliant patients

Locations (1)

Diaconesses Hospital

Paris, France

Outcomes

Primary Outcomes

To assess the efficacy of Eductyl versus placebo for treatment of patients with dyschesia treated by rectal rehabilitation on VAS of intensity of symptoms

Time frame: Day -7, 0, 3, 7, 10, 14, 17, and 21

Secondary Outcomes

To assess the efficacy on change symptoms and safety of Eductyl versus placebo for treatment of patients with dyschesia treated by rectal rehabilitation

Time frame: Day 0 and 21

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.